Comparison of survival between diabetic and non-diabetic patients on maintenance hemodialysis: A single-centre experience

Comorbidities and survival of patients with type 1 diabetes on renal replacement therapy

“…Foley et al found that cardiac failure, left ventricular hypertrophy and ischaemic heart disease associate with increased mortality among diabetes patients on RRT, but they did not study peripheral vascular disease [11]. A Croatian study reported coronary artery disease as one of the most important predictors of death among 44 patients with diabetes on haemodialysis [15].…”

Biochemical Variables and Survival of Patients with Type 1 Diabetes on Renal Replacement Therapy

“…Patients with diabetes on RRT also seem to differ from other patients on RRT. Hyperphosphatemia [17,18] and anemia [18,19,20] are shown to associate with worse survival in ESRD patients in general, but the studies on ESRD patients with diabetes [6,10,11,13,19 did not show this association]. In most studies, the reason for the insignificant effect of hemoglobin on mortality in patients with diabetes and a significant effect in other ESRD patients remains unclear.…”

“…HbA1c is a known risk factor of death among patients with type 1 diabetes [3,4,5], but when the disease has progressed to ESRD, studies (on type 1 and 2 diabetes patients combined) have presented conflicting results [6,7,8]. One study on patients with type 1 diabetes complicated by overt nephropathy showed a correlation between mortality and anemia [9], but in other studies among ESRD patients with diabetes, this correlation was nonsignificant [6,10,11]. The usefulness of creatinine and glomerular filtration rate [6,12] and cholesterol [10,13] for prediction of death has also been conflicting.…”

“…One study on patients with type 1 diabetes complicated by overt nephropathy showed a correlation between mortality and anemia [9], but in other studies among ESRD patients with diabetes, this correlation was nonsignificant [6,10,11]. The usefulness of creatinine and glomerular filtration rate [6,12] and cholesterol [10,13] for prediction of death has also been conflicting.…”

Cardiovascular Risk Assessment in Diabetes and Chronic Kidney Diseases: A New Insight and Emerging Strategies

“…It is also a major CV risk. Despite medications and attempts to control these CV risk factors, CV events still remain the most www.intechopen.com common cause of mortality both in DM and in ESRD [47][48][49]. While a greater risk of CV events is expected in DM compared to non-DM patients with ESRD , the available reports regarding the risk profile in DM and non-DM patients with ESRD are conflicting [42,43,[50][51][52][53].…”